Estimating influenza vaccine effectiveness using routine surveillance data among children aged 6-59 months for five consecutive influenza seasons

被引:16
|
作者
Su, Wei-Ju [1 ,2 ,3 ]
Chan, Ta-Chien [4 ]
Chuang, Pei-Hung [5 ]
Liu, Yu-Lun [1 ]
Lee, Ping-Ing [3 ]
Liu, Ming-Tsan [1 ]
Chuang, Jen-Hsiang [1 ,6 ]
机构
[1] Minist Hlth & Welf, Ctr Dis Control, Taipei 10050, Taiwan
[2] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan
[4] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan
[5] Taiwan Fdn Poison Control, Taipei, Taiwan
[6] Natl Yang Ming Univ, Inst Hlth Care Adm, Taipei 112, Taiwan
关键词
Influenza vaccine effectiveness; Case-control studies; Influenza surveillance; LABORATORY-CONFIRMED INFLUENZA; IMMUNIZATION PRACTICES ACIP; TEST-NEGATIVE DESIGN; HEALTHY-CHILDREN; ADVISORY-COMMITTEE; TRIVALENT; EFFICACY; VIRUS; HOSPITALIZATIONS; RECOMMENDATIONS;
D O I
10.1016/j.ijid.2014.11.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: We aimed to estimate the pooled vaccine effectiveness (VE) in children over five winters through data linkage of two existing surveillance systems. Methods: Five test-negative case-control studies were conducted from November to February during the 2004/2005 to 2008/2009 seasons. Sentinel physicians from the Viral Surveillance Network enrolled children aged 6-59 months with influenza-like illness to collect throat swabs. Through linking with a nationwide vaccination registry, we measured the VE with a logistic regression model adjusting for age, gender, and week of symptom onset. Both fixed-effects and random-effects models were used in the meta-analysis. Results: Four thousand four hundred and ninety-four subjects were included. The proportion of influenza test-positive subjects across the five seasons was 11.5% (132/1151), 7.2% (41/572), 23.9% (189/791), 6.6% (75/1135), and 11.2% (95/845), respectively. The pooled VE was 62% (95% confidence interval (CI) 48-83%) in both meta-analysis models. By age category, VE was 51% (95% CI 23-68%) for those aged 6-23 months and 75% (95% CI 60-84%) for those aged 24-59 months. Conclusions: Influenza vaccination provided measurable protection against laboratory-confirmed influenza among children aged 6-59 months despite variations in the vaccine match during the 2004/2005 to 2008/2009 influenza seasons in Taiwan. (C) 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 50 条
  • [1] Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007
    Staat, Mary Allen
    Griffin, Marie R.
    Donauer, Stephanie
    Edwards, Kathryn M.
    Szilagyi, Peter G.
    Weinberg, Geoffrey A.
    Hall, Caroline B.
    Prill, Mila M.
    Chaves, Sandra S.
    Bridges, Carolyn B.
    Poehling, Katherine A.
    Fairbrother, Gerry
    VACCINE, 2011, 29 (48) : 9005 - 9011
  • [2] Seasonal Influenza Vaccine Effectiveness among Children Aged 6 to 59 Months in Southern China
    Yang, Zhicong
    Dong, Zhiqiang
    Fu, Chuanxi
    PLOS ONE, 2012, 7 (01):
  • [3] The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons
    Katayose, Masahiko
    Hosoya, Mitsuaki
    Haneda, Takashi
    Yamaguchi, Hideo
    Kawasaki, Yukihiko
    Sato, Masatoki
    Wright, Peter F.
    VACCINE, 2011, 29 (09) : 1844 - 1849
  • [4] Effectiveness of Trivalent Influenza Vaccine among Children in Two Consecutive Seasons in a Community in Japan
    Suzuki, Tsubasa
    Ono, Yasuhiko
    Maeda, Hidenori
    Tsujimoto, Yoshiki
    Shobugawa, Yugo
    Dapat, Clyde
    Hassan, Mohd Rohaizat
    Yokota, Chihiro
    Kondo, Hiroki
    Dapat, Isolde C.
    Saito, Kousuke
    Saito, Reiko
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 232 (02) : 97 - 104
  • [5] Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data
    Jimenez-Jorge, S.
    de Mateo, S.
    Delgado-Sanz, C.
    Pozo, F.
    Casas, I.
    Garcia-Cenoz, M.
    Castilla, J.
    Rodriguez, C.
    Vega, T.
    Quinones, C.
    Martinez, E.
    Vanrell, J. M.
    Gimenez, J.
    Castrillejo, D.
    Altzibar, J. M.
    Carril, F.
    Ramos, J. M.
    Serrano, M. C.
    Martinez, A.
    Torner, N.
    Perez, E.
    Gallardo, V.
    Larrauri, A.
    EUROSURVEILLANCE, 2015, 20 (28)
  • [6] Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States
    Luce, Bryan R.
    Nichol, Kristin L.
    Belshe, Robert B.
    Frick, Kevin D.
    Li, Su Xia
    Boscoe, Audra
    Rousculp, Matthew D.
    Mahadevia, Parthiv J.
    VACCINE, 2008, 26 (23) : 2841 - 2848
  • [7] Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons
    Boikos, Constantina
    McGovern, Ian
    Molrine, Deborah
    Ortiz, Justin R.
    Puig-Barbera, Joan
    Haag, Mendel
    VACCINES, 2022, 10 (06)
  • [8] Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons
    Claeys, Carine
    Zaman, Khalequ
    Dbaibo, Ghassan
    Li, Ping
    Izu, Allen
    Kosalaraksa, Pope
    Rivera, Luis
    Acosta, Beatriz
    Arroba Basanta, Maria Luisa
    Aziz, Asma
    Angel Cabanero, Miguel
    Chandrashekaran, Vijayalakshmi
    Corsaro, Bartholomew
    Cousin, Luis
    Diaz, Adolfo
    Diez-Domingo, Javier
    Dinleyici, Ener Cagri
    Faust, Saul N.
    Friel, Damien
    Garcia-Sicilia, Jose
    Gomez-Go, Grace D.
    Antoinette Gonzales, Maria Liza
    Hughes, Stephen M.
    Jackowska, Teresa
    Kant, Shashi
    Lucero, Marilla
    Malvaux, Ludovic
    Mares Bermudez, Josep
    Martinon-Torres, Federico
    Miranda, Mariano
    Montellano, May
    Peix Sambola, Maria Amor
    Prymula, Roman
    Puthanakit, Thanyawee
    Ruzkova, Renata
    Sadowska-Krawczenko, Iwona
    Salamanca de la Cueva, Ignacio
    Sokal, Etienne
    Soni, Jyoti
    Szymanski, Henryk
    Ulied, Angels
    Schuind, Anne
    Jain, Varsha K.
    Innis, Bruce L.
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (05) : 338 - 349
  • [9] Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China
    Wang, Yin
    Zhang, Tao
    Chen, Liling
    Greene, Carolyn
    Ding, Yunfang
    Cheng, Yuejia
    Yang, Chao
    Zeng, Shanshan
    Hua, Jun
    Zhou, Suizan
    Song, Ying
    Luan, Lin
    Zhang, Jun
    Zhao, Genming
    VACCINE, 2016, 34 (21) : 2460 - 2465
  • [10] Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age
    Mallory, Raburn M.
    Yi, Tingting
    Ambrose, Christopher S.
    VACCINE, 2011, 29 (26) : 4322 - 4327